Happy Health wins FDA clearance for cuffless blood pressure ring

Happy Health says the FDA cleared its Happy Ring to measure continuous, clinical-grade blood pressure without a cuff or external calibration. The move could expand around-the-clock monitoring and pair blood pressure data with the ring’s existing at-home sleep apnea diagnosis capabilities.

Why it matters: - The clearance gives clinicians a new way to track blood pressure continuously through day and night, instead of relying on one-off cuff readings. - Happy Health says the technology could surface nighttime and everyday blood pressure patterns that are missed in traditional office measurements. - The approval also links blood pressure monitoring with the Happy Ring’s existing FDA-cleared sleep apnea diagnosis, creating a broader home-based cardiovascular and sleep care workflow.

What happened: - Happy Health announced on October 5, 2026, that the FDA cleared its Happy Ring to measure continuous, clinical-grade blood pressure. - The company says the Happy Ring is the first wearable cleared for ongoing, passive blood pressure measurement without an inflatable cuff or external calibration. - Happy Health is based in Texas and builds a physician-guided digital health platform for care in the home.

The details: - Happy Health validated the blood pressure technology against invasive arterial-line measurements, which are used as a clinical reference standard. - The FDA validation included 850 paired measurements across 85 patients. - The study covered blood pressure readings from normal levels through Stage 2 hypertension. - The patient group included people across age, sex, BMI and skin tone, and no subjects were excluded from the analysis. - The technology showed a 0.8 mmHg mean error for systolic blood pressure and a 0.1 mmHg mean error for diastolic blood pressure. - The Happy Ring captures more than 2.8 million medical data points each night across sleep, respiratory, cardiovascular, neurological and metabolic systems. - Happy Health says its AI platform builds a personalized model of each person’s health and learns what is normal for that individual. - Board-certified physicians in Happy Health’s 50-state network interpret results, make clinical decisions and guide diagnosis and care. - The Happy Ring is already FDA-cleared for at-home obstructive sleep apnea diagnosis. - The device is the first and only FDA-cleared smart ring for at-home diagnosis of obstructive sleep apnea, with a physician-rendered diagnosis in as few as five nights and 98% accuracy compared with in-lab polysomnography.

Between the lines: - The clearance pushes wearables closer to replacing traditional cuff-based spot checks with passive monitoring that can run continuously in the background. - Happy Health is positioning personalized modeling as the next step beyond population averages, with the ring designed to detect meaningful changes earlier. - The company is also linking sleep apnea and blood pressure, two conditions that often reinforce one another and can raise cardiovascular risk when left untreated. - Happy Health says continuous overnight tracking could help physicians intervene earlier, before these conditions progress into cardiovascular disease.

What's next: - Happy Health is likely to expand clinical use of the Happy Ring as physicians gain access to continuous blood pressure data alongside sleep apnea results. - The company raised $75 million from ARCH Venture Partners and OpenLoop in August 2026, giving it additional capital to push commercialization and clinical adoption. - Happy Health says its broader goal is to bring diagnosis and treatment into the home through wearable sensors, AI and physician oversight.

The bottom line: - Happy Health now has FDA clearance for what it says is the first cuffless, calibrationless wearable blood pressure monitor, a notable step toward continuous home-based cardiovascular monitoring.